sandostatin
Generic: octreotide acetate
Labeler: novartis pharmaceuticals corporationDrug Facts
Product Profile
Brand Name
sandostatin
Generic Name
octreotide acetate
Labeler
novartis pharmaceuticals corporation
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
octreotide acetate 100 ug/mL
Manufacturer
Identifiers & Regulatory
Product NDC
0078-0181
Product ID
0078-0181_ad42b59d-8ad5-4855-96a9-f40c7ef4a7e3
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA019667
Listing Expiration
2026-12-31
Marketing Start
1988-10-21
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
00780181
Hyphenated Format
0078-0181
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
sandostatin (source: ndc)
Generic Name
octreotide acetate (source: ndc)
Application Number
NDA019667 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 100 ug/mL
Packaging
- 10 AMPULE in 1 PACKAGE (0078-0181-01) / 1 mL in 1 AMPULE (0078-0181-61)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "ad42b59d-8ad5-4855-96a9-f40c7ef4a7e3", "openfda": {"unii": ["75R0U2568I"], "rxcui": ["207194", "207198", "207200", "312068", "312069", "312070"], "spl_set_id": ["4e2c9856-1836-49f0-9472-4dbeeb408f39"], "manufacturer_name": ["Novartis Pharmaceuticals Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 AMPULE in 1 PACKAGE (0078-0181-01) / 1 mL in 1 AMPULE (0078-0181-61)", "package_ndc": "0078-0181-01", "marketing_start_date": "19881021"}], "brand_name": "Sandostatin", "product_id": "0078-0181_ad42b59d-8ad5-4855-96a9-f40c7ef4a7e3", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Somatostatin Analog [EPC]", "Somatostatin Receptor Agonists [MoA]"], "product_ndc": "0078-0181", "generic_name": "octreotide acetate", "labeler_name": "Novartis Pharmaceuticals Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Sandostatin", "active_ingredients": [{"name": "OCTREOTIDE ACETATE", "strength": "100 ug/mL"}], "application_number": "NDA019667", "marketing_category": "NDA", "marketing_start_date": "19881021", "listing_expiration_date": "20261231"}